Author:
Rosenberg Carina A.,Rodrigues Matthew A.,Bill Marie,Ludvigsen Maja
Abstract
AbstractMyelodysplastic syndrome is primarily characterized by dysplasia in the bone marrow (BM), presenting a challenge in consistent morphology interpretation. Accurate diagnosis through traditional slide-based analysis is difficult, necessitating a standardized objective technique. Over the past two decades, imaging flow cytometry (IFC) has proven effective in combining image-based morphometric analyses with high-parameter phenotyping. We have previously demonstrated the effectiveness of combining IFC with a feature-based machine learning algorithm to accurately identify and quantify rare binucleated erythroblasts (BNEs) in dyserythropoietic BM cells. However, a feature-based workflow poses challenges requiring software-specific expertise. Here we employ a Convolutional Neural Network (CNN) algorithm for BNE identification and differentiation from doublets and cells with irregular nuclear morphology in IFC data. We demonstrate that this simplified AI workflow, coupled with a powerful CNN algorithm, achieves comparable BNE quantification accuracy to manual and feature-based analysis with substantial time savings, eliminating workflow complexity. This streamlined approach holds significant clinical value, enhancing IFC accessibility for routine diagnostic purposes.
Funder
Max Wørzner and wife Inger Wørzner's Foundation
Danish Cancer Society
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20), 2391–2405 (2016).
2. Garcia-Manero, G., Chien, K. & Montalban-Bravo, G. Myelodysplastic syndromes: 2021 update on diagnosis, risk-stratification and management. Am. J. Hematol. 95, 1399–1420 (2020).
3. Hasserjian, R. P., Orazi, A., Orfao, A., Rozman, M. & Wang, S. A. The International Consensus Classification of myelodysplastic syndromes and related entities. Virchows Arch. 482, 39–51 (2023).
4. Sekeres, M. A. & Taylor, J. Diagnosis and treatment of myelodysplastic syndromes: A review. JAMA 328, 872–880 (2022).
5. Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition (International Agency for Research on Cancer, 2017).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献